The current study was designed to test the hypothesis that DEX attenuates LPS-induced ALI through the inhibition of lung inflammation and apoptosis via the promotion of TIPE2 expression and the inhibition of the NF-κB and JNK pathways, which might indicate its potential application in lung injury therapy. This evidence concerns the gene MAPK8 and acute respiratory distress syndrome.